Women who used newer-generation SSRIs such as Zoloft is believed to be at risk of developing breast cancer according to a research conducted by the Cancer Care Ontario.
Researchers suggest that this could be because antidepressants affect the enzymes (the proteins that speed up chemical reactions in the body) involved with the metabolism ( the bodys processing) of carcinogens and estrogen, both of which are linked to breast cancer.
It was a case-control study in 1995-1996 conducted by researchers in which they identified 700 women who had been diagnosed with breast cancer at that time and compared them with a random sample of 700 women who had not been diagnosed with breast cancer during that period.
However, until now the research data regarding the use of SSRI and breast cancer is highly controversial, according to the wellness resources website that accuses big pharmaceutical companies of funding scientist for hire to cranked out studies that denies the association of the antidepressants and breast cancer, which is a blatant and fraudulent misrepresentation of SSRI risks and benefits.
61 studies was reviewed associating the use of antidepressant can cause breast cancer as stated in an issue in the April 2011 open-access article published in Plos One21.
An 11% increase in risk for breast cancer was associated with all types of antidepressants as stated in the overall data. There is an increased risk of cancer among women with the use of SSRI antidepressants.
The April 2011 studies also evaluate the relationship of the authors with the makers of antidepressants.
Shockingly, none of the 15 researchers with financial ties to the industry found any risk of breast cancer in the studies they conducted, whereas 43 % of the researchers without industry ties found clear evidence of cancer risk. 43% of the researchers without industry ties found clear indication of cancer risk while surprisingly, none of the 15 researchers funded by the industry found any risk of breast cancer in their studies.
An SSRI antidepressant drug linked with breast cancer such as Zoloft, which causes Zoloft birth defect, is still the center of several debates and thorough research. Several lawsuits and billions of dollars will be lost if the allegation is proven against pharmaceutical companies.